Studies have reported significantly increased diagnostic sensitivity of uPA compared to CA19-9 in colon and colorectal cancers, however, there is a lack of similar studies available for pancreatic cancer [133]. This evidence concerns the gene PLAU and familial pancreatic carcinoma.